All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-T-2-LX492 | Anti-HIV (M66.6) (CD4-scFv-h(CD28-CD3ζ)) bNAb CAR, pCDCAR1 | Human | M66.6 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX493 | Anti-HIV (CAP206-CH12) (CD4-scFv-h(CD28-CD3ζ)) bNAb CAR, pCDCAR1 | Human | CAP206-CH12 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX494 | Anti-HIV (2F5) (CD4-scFv-h(CD28-CD3ζ)) bNAb CAR, pCDCAR1 | Human | 2F5 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX495 | Anti-HIV (4E10) (CD4-scFv-h(CD28-CD3ζ)) bNAb CAR, pCDCAR1 | Human | 4E10 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX556 | Anti-HIV (Z13) (CD4-scFv-h(CD28-CD3ζ)) CAR, pCDCAR1 | Human | Z13 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX557 | Anti-HIV (10E8) (CD4-scFv-h(CD28-CD3ζ)) CAR, pCDCAR1 | Human | 10E8 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX590 | Anti-HIV (VRC42.01) (CD4-scFv-h(CD28-CD3ζ)) bNAb CAR, pCDCAR1 | Human | VRC42.01 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX591 | Anti-HIV (VRC43.01) (CD4-scFv-h(CD28-CD3ζ)) bNAb CAR, pCDCAR1 | Human | VRC43.01 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX592 | Anti-HIV (VRC46.01) (CD4-scFv-h(CD28-CD3ζ)) bNAb CAR, pCDCAR1 | Human | VRC46.01 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX593 | Anti-HIV (VRC42.N1) (CD4-scFv-h(CD28-CD3ζ)) CAR, pCDCAR1 | Human | VRC42.N1 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX733 | Anti-HIV (M66.6) (CD4-scFv-h(4-1BB-CD3ζ)) bNAb CAR, pCDCAR1 | Human | M66.6 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX734 | Anti-HIV (CAP206-CH12) (CD4-scFv-h(4-1BB-CD3ζ)) bNAb CAR, pCDCAR1 | Human | CAP206-CH12 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX735 | Anti-HIV (2F5) (CD4-scFv-h(4-1BB-CD3ζ)) bNAb CAR, pCDCAR1 | Human | 2F5 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX736 | Anti-HIV (4E10) (CD4-scFv-h(4-1BB-CD3ζ)) bNAb CAR, pCDCAR1 | Human | 4E10 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX797 | Anti-HIV (Z13) (CD4-scFv-h(4-1BB-CD3ζ)) CAR, pCDCAR1 | Human | Z13 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX798 | Anti-HIV (10E8) (CD4-scFv-h(4-1BB-CD3ζ)) CAR, pCDCAR1 | Human | 10E8 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX831 | Anti-HIV (VRC42.01) (CD4-scFv-h(4-1BB-CD3ζ)) bNAb CAR, pCDCAR1 | Human | VRC42.01 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX832 | Anti-HIV (VRC43.01) (CD4-scFv-h(4-1BB-CD3ζ)) bNAb CAR, pCDCAR1 | Human | VRC43.01 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX833 | Anti-HIV (VRC46.01) (CD4-scFv-h(4-1BB-CD3ζ)) bNAb CAR, pCDCAR1 | Human | VRC46.01 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX834 | Anti-HIV (VRC42.N1) (CD4-scFv-h(4-1BB-CD3ζ)) CAR, pCDCAR1 | Human | VRC42.N1 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION